Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Novartis Pays Regenxbio $100 Million for Gene Therapy Technology Under AveXis License Agreement

Rockville, Md.-based REGENXBIO snagged $100 million from Novartis under its license agreement with gene-therapy company AveXis, which the Swiss company acquired for $8.7 billion earlier in 2018.

Read More »

J&J Announces Binding Offer from Fortive to Acquire Advanced Sterilization Products

Johnson & Johnson received a binding offer to sell its Advanced Sterilization Products (ASP) business to Fortive Corporation. The deal is valued at $2.8 billion.

Read More »

Syneos Health Consulting Releases 10th Annual Biopharmaceutical Dealmakers Survey

The tenth annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading consulting firm specializing in the biopharmaceutical industry, concludes that the dealmaking environment will continue to accelerate with buyers becoming more selective in ensuring they have the most appropriate assets and corresponding deals in place.

Read More »

Alibaba injects pharmacy assets into healthcare unit in $1.4 billion deal

Chinese e-commerce giant Alibaba Group Holding Ltd. will inject some of its online pharmacy business into a listed unit in a deal valued at HK$10.6 billion ($1.35 billion), the firm said in a statement.

Read More »

Takeda Selling Chinese Joint Venture

Ahead of Takeda Pharmaceutical’s acquisition of Dublin-based Shire, the Japan-based company is divesting its majority stake in a Chinese joint venture for about $280 million.

Read More »

Sivantos and Widex in $8 billion merger

Hearing aid makers Widex and Sivantos are merging to create an industry No. 3 that can invest more in digital devices and step up the challenge to market leaders Sonova and William Demant.

Read More »

Takeda Pharma to Buy Shire for $62.2 Billion

Dublin-based Shire agreed to be acquired by Japan-based Takeda Pharmaceutical, with both boards approving the deal.

Read More »

Akorn sues Fresenius over deal termination

U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement.

Read More »

Sanofi to Sell Generics Division to Advent

Paris-based Sanofi agreed to sell the company’s generics division Zentiva to the private equity firm Advent International for 1.9 billion euros ($2.4 billion). The deal is expected to wrap by year-end 2018.

Read More »

Cigna to buy Express Scripts

U.S. health insurer Cigna Corp. will buy pharmacy benefits manager Express Scripts Holding Co., a tie-up that reflects pressure on healthcare companies to grow bigger to cut costs.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom